Summary
Systemic and localised adverse effects of local anaesthetic drugs usually occur because of excessive dosage, rapid absorption or inadvertent intravascular injection.
Small children are more prone than adults to methaemoglobinaemia, and the combination of sulfonamides and prilocaine, even when correctly administered, should be avoided in this age group. The incidence of true allergy to local anaesthetics is rare.
All local anaesthetics can cause CNS toxicity and cardiovascular toxicity if their plasma concentrations are increased by accidental intravenous injection or an absolute overdose. Excitation of the CNS may be manifested by numbness of the tongue and perioral area, and restlessness, which may progress to seizures, respiratory failure and coma. Bupivacaine is the local anaesthetic most frequently associated with seizures. Treatment of CNS toxicity includes maintaining adequate ventilation and oxygenation, and controlling seizures with the administration of thiopental sodium or benzodiazepines.
Cardiovascular toxicity generally begins after signs of CNS toxicity have occurred. Bupivacaine and etidocaine appear to be more cardiotoxic than most other commonly used local anaesthetics. Sudden onset of profound bradycardia and asystole during neuraxial blockade is of great concern and the mechanism(s) remains largely unknown. Treatment of cardiovascular toxicity depends on the severity of effects. Cardiac arrest caused by local anaesthetics should be treated with cardiopulmonary resuscitation procedures, but bupivacaine-induced dysrhythmias may be refractory to treatment.
Many recent reports of permanent neurological complications involved patients who had received continuous spinal anaesthesia through a microcatheter. Injection of local anaesthetic through microcatheters and possibly small-gauge spinal needles results in poor CSF mixing and accumulation of high concentrations of local anaesthetic in the areas of the lumbosacral nerve roots. In contrast to bupivacaine, the hyperbaric lidocaine (lignocaine) formulation carries a substantial risk of neurotoxicity when given intrathecally.
Drugs altering plasma cholinesterase activity have the potential to decrease hydrolysis of ester-type local anaesthetics. Drugs inhibiting hepatic microsomal enzymes, such as cimetidine, may allow the accumulation of unexpectedly high (possibly toxic) blood concentrations of lidocaine. Reduction of hepatic blood flow by drugs or hypotension will decrease the hepatic clearance of amide local anaesthetics. Special caution must be exercised in patients taking digoxin, calcium antagonists and/or β-blockers.
Similar content being viewed by others
References
Catterall WA. Common modes of drug action on Na+ channels: local anesthetics, antiarrhythmics, and anticonvulsants. Trends Pharmacol Sci 1987; 8: 57–65
Al-Mazrooa AA, Abdel-Halim RE. Anaesthesia 1000 years ago. In: Atkinson RS, Boulton TB, editors. The history of anaesthesia. International Congress and Symposium series Number 134. London: The Parthenon Publishing Group, 1989: 46–8
Koller C. Ueber die Verwendung des Cocain zur Anaesthesierung am Auge. Wien Med Wochenschr 1884; 34: 1276–8
Boyes RM, Scott DB, Jebson PJ, et al. Pharmacokinetics of lidocaine in man. Clin Pharmacol Ther 1971; 12: 105–16
Aldrete JA, Romo-Salas F, Arora S, et al. Reverse arterial blood flow as a pathway for central nervous system toxic responses following injection of local anesthetics. Anesth Analg 1978; 57: 428–33
Meyers EF, Ramirez RC, Boniuk I. Grand mal seizures after retrobulbar block. Arch Ophthalmol 1978; 96: 847
Nau H. Clinical pharmacokinetics in pregnancy and perinatology. I: placental transfer and fetal side effects of local anaesthetic agents. Dev Pharmacol Ther 1985; 8: 149–81
Covino BG. Pharmacokinetics of local anesthetic drugs. In: Prys-Roberts C, Hug Jr C, editors. Pharmacokinetics of anesthesia. Oxford: Blackwell Scientific Publications, 1984: 202
Bromage PR, Robson JG. Concentrations of lidocaine in the blood after intravenous, intramuscular, epidural, and endotracheal administration. Anaesthesia 1961; 16: 461–78
Wildsmith JA, Tucker GT, Cooper S, et al. Plasma concentrations of local anaesthetics after interscalene brachial plexus block. Br J Anaesth 1977; 49: 461–6
Covino BG. Comparative clinical pharmacology of local anaesthetic agents. Anesthesiology 1971; 35: 158–67
Anaesthetists and the reporting of adverse drug reactions. BMJ 1986; 292: 949
Naguib M, Magboul MMA, Jaroudi R. Clinically significant drug interactions with general anaesthetics: incidence, mechanisms and management. CNS Drugs 1997; 8: 51–78
Olson ML, McEvoy GK. Methemoglobinemia induced by local anesthetics. Am J Hosp Pharm 1981; 38: 89–93
Severinghaus JW, Xu Fa-Di, Spellman Jr MJ. Benzocaine and methemoglobin: recommended action [letter]. Anesthesiology 1991; 74: 385
Sherman JM, Smith K. Methemoglobinemia owing to rectal-probe lubrication [letter]. Am J Dis Child 1979; 133: 439
Seibert RW, Seibert JJ. Infantile methemoglobinemia induced by a topical anesthetic, cetacaine. Laryngoscope 1984; 94: 816–7
Bhatt DN, Bifano EM, Stark DCC. Postoperative methemoglobinemia in a neonate [letter]. Anesthesiology 1985; 62: 210–1
Kellett PB, Copeland CS. Methemoglobinemia associated with benzocaine-containing lubricant. Anesthesiology 1983; 59: 463–4
Ferraro-Borgida MJ, Mulhern SA, DeMeo MO, et al. Methemoglobinemia from perineal application of an anesthetic cream. Ann Emerg Med 1996; 27: 785–8
O’Donohue Jr WJ, Moss LM, Angelilo VA. Acute methemoglobinemia induced by topical benzocaine and lidocaine. Arch Intern Med 1980; 140: 1508–9
Spielman FJ, Anderson JA, Terry WC. Benzocaine-induced methemoglobinemia during general anesthesia. J Oral Maxillofac Surg 1984; 42: 740–3
Potter JL, Hillman JV. Benzocaine-induced methemoglobinemia. J Am Coll Emerg Phys 1979; 8: 26–7
Jakobson B, Nilsson A. Methemoglobinaemia associated with a prilocaine-lidocaine cream and trimetoprim-sulphamethoxazole: a case report. Acta Anaesthesiol Scand 1985; 29: 453–5
Engberg G, Danielson K, Henneberg S, et al. Plasma concentrations of prilocaine and lidocaine and methaemoglobin formation in infants after epicutaneous application of a 5% lidocaine-prilocaine cream (EMLA). Acta Anaesthesiol Scand 1987; 31: 624–8
Duncan PG, Kobrinsky N. Prilocaine-induced methemoglobinemia in a newborn infant. Anesthesiology 1983; 59: 75–6
Kreutz RW, Kinni ME. Life-threatening toxic methemoglobinemia induced by prilocaine. Oral Surg 1983; 56: 480–2
Frayling IM, Addison GM, Chattergee K, et al. Methaemoglobinaemia in children treated with prilocaine-lignocaine cream. BMJ 1990; 301: 153–4
Bardoczky GI, Wathieu M, D’Hollander A. Prilocaine-induced methemoglobinemia evidenced by pulse oximetry. Acta Anaesthesiol Scand 1990; 34: 162–4
Klos CP, Hays GL. Prilocaine-induced methemoglobinemia in a child with Shwachman syndrome. J Oral Maxillofac Surg 1985; 43: 621–3
Weiss LD, Generalovich T, Heller MB, et al. Methemoglobin levels following intravenous lidocaine administration. Ann Emerg Med 1987; 16: 323–5
Nilsson A, Engberg G, Henneberg S, et al. Inverse relationship between age-dependent erythrocyte activity of methaemoglobin reductase and prilocaine-induced methaemoglobinaemia during infancy. Br J Anaesth 1990; 64: 72–6
Curry S. Methemoglobinemia. Ann Emerg Med 1982; 11: 214–21
Reynolds F. Adverse effects of local anaesthetics. Br J Anaesth 1987; 59: 78–95
Finch CA. Methemoglobinemia and sulfhemoglobinemia. N Engl J Med 1948; 239: 470–8
Hall AH, Kulig KW, Rumack BH. Drug- and chemical-induced methaemoglobinaemia: clinical features and management. Med Toxicol 1986; 1: 253–60
Barker SJ, Tremper KK, Hyatt J. Effects of methemoglobinemia on pulse oximetry and mixed venous oximetry. Anesthesiology 1989; 70: 112–7
Anderson ST, Hajduczek J, Barker SJ. Benzocaine-induced methemoglobinemia in an adult: accuracy of pulse oximetry with methemoglobinemia. Anesth Analg 1988; 67: 1099–101
Choe H, Tashiro C, Fukumitsu K, et al. Comparison of recorded values from six pulse oximeters. Crit Care Med 1989; 17: 678–81
Lukens JN. Methemoglobinemia and other diseases accompanied by cyanosis. In: Lee GR, Bithell TC, Foerster J, editors. Wintrobe’s clinical hematology. 9th edition. Philadelphia: Lea & Febiger, 1993: 1262–71
Odoom JA, Dokter PWC, Sturk A, et al. The influence of epidural analgesia on platelet function and correlation with plasma bupivacaine concentrations. Eur J Anaesthesiol 1988; 5: 305–12
Modig J, Borg T, Karlström G, et al. Thromboembolism after total hip replacement: role of epidural and general anesthesia. Anesth Analg 1983; 62: 174–80
McKenzie PJ, Wishart HY, Gray I, et al. Effects of anaesthetic techniques on deep vein thrombosis: a comparison of subarachnoid and general anaesthesia. Br J Anaesth 1985; 57: 853–7
Bowler GMR, Lamont MC, Scott DB. Effect of extradural bupivacaine or i.v. diamorphine on calf blood flow in patients after surgery. Br J Anaesth 1987; 59: 1412–9
Davis FM, McDermott E, Hickton C, et al. Influence of spinal and general anaesthesia on haemostasis during total hip arthroplasty. Br J Anaesth 1987; 59: 561–71
Modig J, Borg T, Bagge EL, et al. Role of extradural and general anaesthesia in fibrinolysis and coagulation after total hip replacement. Br J Anaesth 1983; 53: 625–9
Henny CP, Odoom JA, Ten Cate H, et al. Effects of extradural bupivacaine on the haemostatic system. Br J Anaesth 1986; 58: 301–5
Giddon DB, Lindhe J. In vivo quantitation of local anesthetic suppression of leukocyte adherence. Am J Pathol 1972; 68: 327–38
Chen RYZ, Lee MM, Chien S. Local anesthetics and the rheologic behavior of erythrocyte suspension. Anesthesiology 1979; 51: 245–50
Odoom JA, Bovill JG, Hardeman MR, et al. Effects of epidural and spinal anesthesia on blood rheology. Anesth Analg 1992; 74: 538–40
Hammer R, Dahlgren C, Stendahl O. Inhibition of human leukocyte metabolism and random mobility by local anaesthesia. Acta Anaesthesiol Scand 1985; 29: 520–3
Goldstein IM, Lind S, Hoffstein S, et al. Influence of local anesthetics upon human polymorphonuclear leukocyte function in vitro: reduction of lysosomal enzyme release and superoxide anion production. J Exp Med 1977; 146: 483–94
Nakagawara M, Hirokata Y, Yoshitake J. Effects of anesthetics on superoxide releasing activity on human polymorphonuclear leukocytes. Masui 1985; 34: 754–9
Eriksson AS, Sinclair R, Cassuto J, et al. Influence of lidocaine on leukocyte function in the surgical wound. Anesthesiology 1992; 77: 74–8
Kanta J, Kopacova L, Patockova M, et al. Effect of carbanilate local anesthetics on granulation tissue formation. Pol J Pharmacol Pharm 1984; 36: 659–63
Davies B, Guyuron B, Husami T. The role of lidocaine, epinephrine, and flap elevation in wound healing after chemical peel. Ann Plast Surg 1991; 26: 273–8
Concepcion M, Covino BG. Rational use of local anaesthetics. Drugs 1984; 27: 256–70
Sisk AL. Comparison of etidocaine and lidocaine for control of intra- and post-operative bleeding and pain. J Oral Maxillofac Surg 1986; 44: 16–20
Jones RA, Di Fazio CA, Longnecker DE. Lidocaine constricts or dilates rat arterioles in a dose-dependent manner. Anesthesiology 1985; 62: 141–4
Hogan Q. Local anesthetic toxicity: an update. Reg Anesth 1996; 21 Suppl. 6: 43–50
Sprung J, Lesitsky MA, Jagetia A, et al. Cardiac arrest caused by coronary spasm in two patients during recovery from epidural anesthesia. Reg Anesth 1996; 21: 253–60
Brockway MS, Bannister J, McClure JH, et al. Comparison of extradural ropivacaine and bupivacaine. Br J Anaesth 1991; 66: 31–7
De Jong RH. Toxic effects of local anesthetics. JAMA 1978; 239: 1166–8
Liu P, Feldman HS, Giasi, et al. Comparative CNS toxicity of lidocaine, etidocaine, bupivacaine and tetracaine in awake dogs following rapid intravenous administration. Anesth Analg 1983; 62: 375–9
Garner L, Stirt J, Finholt D. Heart block after intravenous lidocaine in an infant. Can Anaesth Soc J 1985; 32: 425–8
Heavner JE, Dryden Jr CF, Sanghani V, et al. Severe hypoxia enhances central nervous system and cardiovascular toxicity of bupivacaine in lightly anesthetized pigs. Anesthesiology 1992; 77: 142–7
Avery P, Reden D, Schaenzer G, et al. The influence of serum potassium on the cerebral and cardiac toxicity of bupivacaine and lidocaine. Anesthesiology 1984; 61: 134–8
Moller RA, Datta S, Fox J, et al. Effects of progesterone on the cardiac action electrophysiologic action of bupivacaine and lidocaine. Anesthesiology 1992; 76: 604–8
Santos AC, Arthur GR, Wlody D, et al. Comparative systemic toxicity of ropivacaine and bupivacaine in nonpregnant and pregnant ewes. Anesthesiology 1995; 82: 734–40
Thomas RD, Behbehani MM, Coyle DE, et al. Cardiovascular toxicity of local anesthetics. An alternative hypothesis. Anesth Analg 1986; 65: 444–50
Blair MR. Cardiovascular physiology of local anaesthetics. Br J Anaesth 1975; 47 Suppl.: 247–52
Cardiotoxicity of local anaesthetic drugs [editorial]. Lancet 1986; II: 1192-4
Albright GA. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine [editorial]. Anesthesiology 1979; 51: 285–7
Nath S, Häggmark S, Johnasson G, et al. Differential depressant and electrophysiologic cardiotoxicity of local anesthetics: an experimental study with special reference to lidocaine and bupivacaine. Anesth Analg 1986; 65: 1263–70
Lynch C III. Depression of myocardial contractility in vitro by bupivacaine, etidocaine, and lidocaine. Anesth Analg 1986; 65: 551–9
Buffington CW. The magnitude and duration of direct myocardial depression following intracoronary local anesthetics: a comparison of lidocaine and bupivacaine. Anesthesiology 1989; 70: 280–7
Fujita Y. Comparative direct effects of lidocaine and bupivacaine on regional myocardial function in dogs at non-cardiovascular toxic levels. Anesth Analg 1994; 78: 1158–63
Reiz S, Häggmark S, Johansson G, et al. Cardiotoxicity of ropivacaine — a new amide local anaesthetic agent. Acta Anaesthesiol Scand 1989; 33: 93–8
Kasten GW, Martin ST. Successful cardiovascular resuscitation after massive intravenous bupivacaine overdosage in anesthetized dogs. Anesth Analg 1985; 64: 491–7
Mazoit JX, Boico O, Samii K. Myocardial uptake of bupivacaine. II: pharmacokinetics and pharmacodynamics of bupivacaine enantiomers in the isolated perfused rabbit heart. Anesth Analg 1993; 44: 477–82
Clarkson CW, Hondeghem IM. Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole. Anesthesiology 1985; 62: 396–405
Coyle DE, Sperelakis N. Bupivacaine and lidocaine blockade of calcium-mediated slow action potentials in guinea pig ventricular muscle. J Pharmacol Exp Ther 1987; 242: 1001–5
Sanchez-Chapula J. Effects of bupivacaine on membrane currents of guinea-pig ventricular myocytes. Eur J Pharmacol 1988; 156: 303–8
Butterworth JF IV, Brownlow RC, Leith JP, et al. Bupivacaine inhibits cyclic-3′,5′-adenosine monophosphate production: a possible contributing factor to cardiovascular toxicity. Anesthesiology 1993; 79: 88–95
Covino BG. Recent advances in local anesthesia. Can Anaesth Soc J 1986; 33: S5–S8
Moore DC, Bridenbaugh LD. Spinal (subarachnoid) block: a review of 11,574 cases. JAMA 1966; 195: 907–12
Moore DC, Bridenbaugh LD, Bagdi PA, et al. The present status of spinal (subarachnoid) and epidural (peridural) block: a comparison of two technics. Anesth Analg 1968; 47: 40–9
Moore DC, Bridenbaugh LD, Bridenbaugh PO, et al. Bupivacaine: a review of 2077 cases. JAMA 1970; 214: 713–8
Bonica JJ, Berges PU, Morikawa K. Circulatory effects of peridural block. I: effects of level of analgesia and doses of lidocaine. Anesthesiology 1970; 33: 619–26
Bonica JJ, Akamatsu TJ, Berges PU, et al. Circulatory effects of peridural block. II: effects of epinephrine. Anesthesiology 1971; 34: 514–22
Wetstone DL, Wong KC. Sinus bradycardia and asystole during spinal anesthesia. Anesthesiology 1974; 41: 87–9
Nishidawa T, Anzai Y, Namiki A. Asystole during spinal anaesthesia after changes from Trendelenburg to horizontal position. Can J Anaesth 1988; 35: 406–8
Fredericks RL, Campbell J, Bassell GM. Psychologic cardiac arrest during extensive sympathetic blockade. Anesthesiology 1988; 68: 943–4
Gild W, Grilley P. Sudden cardiac arrest during epidural anesthesia [letter]. Anesthesiology 1990; 73: 1296
Mackey DC, Carpenter RL, Thompson GE, et al. Bradycardia and asystole during spinal anesthesia: a report of three cases without morbidity. Anesthesiology 1989; 70: 866–8
Liguori GA, Sharrock NE. Asystole and severe bradycardia during epidural anesthesia in orthopedic patients. Anesthesiology 1997; 86: 250–7
Chan KKM, Welch KJ. Cardiac arrest during segmental thoracic epidural anesthesia. Anesthesiology 1997; 86: 502–5
Caplan RA, Ward RJ, Posner K, et al. Unexpected cardiac arrest during spinal anesthesia: a closed claim analysis of predisposing factors. Anesthesiology 1988; 68: 5–11
New classification of physical status. Anesthesiology 1963; 24: 111
Carpenter RL, Caplan RA, Brown DL, et al. Incidence and risk factors for side effects of spinal anesthesia. Anesthesiology 1992; 76: 906–16
Liu S, Paul GE, Carpenter RL, et al. Prolonged PR interval is a risk factor for bradycardia during spinal anesthesia. Reg Anesth 1995; 20: 41–4
Keats AS. Anesthesia mortality — a new mechanism. Anesthesiology 1988; 68: 2–4
Cohen LI. Asystole during spinal anesthesia in a patient with sick sinus syndrome. Anesthesiology 1988; 68: 787–8
Tucker GT, Mather LE. Clinical pharmacokinetics of local anesthetics. Clin Pharmacokinet 1979; 4: 241–78
Leicht CH, Carlson SA. Prolongation of lidocaine spinal anesthesia with epinephrine and phenylephrine. Anesth Analg 1986; 65: 365–9
Feldman HS, Arthur GR, Covino BG. Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine and lidocaine in the conscious dog. Anesth Analg 1989; 69: 794–801
Moore DC, Crawford RD, Scurlock JE. Severe hypoxia and acidosis following local anesthetic induced convulsions. Anesthesiology 1980; 53: 259–60
Mallampati SR, Liu PL, Knapp RM. Convulsion and ventricular tachycardia from bupivacaine with epinephrine; successful resuscitation. Anesth Analg 1984; 63: 856–9
Davis NL, de Jong RH. Successful resuscitation following massive bupivacaine overdose. Anesth Analg 1982; 61: 62–4
Kendig JJ. Clinical implications of the modulated receptor hypothesis: local anesthetics and the heart [editorial]. Anesthesiology 1985; 62: 382–4
Feldman HS, Arthur GR, Pitkanen M, et al. Treatment of acute systemic toxicity after the rapid intravenous injection of ropivacaine and bupivacaine in the conscious dog. Anesth Analg 1991; 73: 373–84
Saitoh K, Hirabayashi Y, Shimizu R, et al. Amrinone is superior to epinephrine in reversing bupivacaine-induced cardiovascular depression in sevoflurane-anesthetized dogs. Anesthesiology 1995; 83: 127–33
Lindgren L, Randell T, Suzuki N, et al. The effect of amrinone on recovery from severe bupivacaine intoxication in pigs. Anesthesiology 1992; 77: 309–15
Heavner JE, Pitkänen MT, Shi B, et al. Resuscitation from bupivacaine-induced asystole in rats: comparison of different cardioactive drugs. Anesth Analg 1995; 80: 1134–9
Lacombe P, Blaise G, Hollmann C, et al. Isoproterenol corrects the effects of bupivacaine on the electrophysiologic properties of the isolated rabbit heart. Anesth Analg 1991; 72: 70–4
Hornchen U, Fischer M, Lauven PM, et al. The cardiotoxicity of bupivacaine during pacemaker stimulation is dependent on the stimulation frequency: results of an experimental study [in German]. Anaesthesist 1993; 42: 350–5
Matsuda F, Kinney WW, Wright W, et al. Nicardipine reduces the cardio-respiratory toxicity of intravenously administered bupivacaine in rats. Can J Anaesth 1990; 37: 920–3
Solomon D, Bunegin L, Albin M. The effect of magnesium sulfate administration on cerebral and cardiac toxicity of bupivacaine in dogs. Anesthesiology 1990; 72: 341–6
Kasten GW, Martin ST. Bupivacaine cardiovascular toxicity: comparison of treatment with bretylium and lidocaine. Anesth Analg 1985; 64: 911–6
Haasio J, Rosenberg PH. Treatment of bupivacaine-induced cardiac arrhythmias in hypoxic and hypercarbic pigs with amiodarone or bretylium. Reg Anesth 1990; 15: 174–9
Clarkson CW, Hondeghem LM. Evidence for a specific receptor site for lidocaine, quinidine, and bupivacaine associated with cardiac sodium channels in guinea pig ventricular myocardium. Circ Res 1985; 56: 496–506
Maxwell LG, Martin LD, Yaster M. Bupivacaine-induced cardiac toxicity in neonates: successful treatment with intravenous phenytoin. Anesthesiology 1994; 80: 682–6
Bigger JT, Hoffman BF. Antiarrhythmic drugs: the pharmacological basis of therapeutics. In: Gilman AG, Rall TW, Nies AS, et al., editors. New York: Pergamon Press, 1990: 840–73
De La Coussaye J, Bassoul B, Brugada J, et al. Reversal of electrophysiologic and hemodynamic effects induced by high dose of bupivacaine by the combination of clonidine and dobutamine in anesthetized dogs. Anesth Analg 1992; 74: 703–11
Wagman IH, De Jong RH, Prince DA. Effects of lidocaine on the central nervous system. Anesthesiology 1967; 28: 155–72
Fruncillo RJ, Gibbons W, Bowman SM. CNS toxicity after ingestion of topical lidocaine. N Engl J Med 1982; 306: 426–7
Ryan CA, Robertson M, Coe JY. Seizures due to lidocaine toxicity in a child during cardiac catheterization. Pediatr Cardiol 1993; 14: 116–8
Sundaram MBM. Seizures after intraurethral instillation of lidocaine. Can Med Assoc J 1987; 137: 219–20
Casale FF. Convulsions following surgery [letter]. Br J Anaesth 1970; 42: 1024
McCloskey JJ, Haun SE, Deshpande JK. Bupivacaine toxicity secondary to continuous caudal epidural infusion in children. Anesth Analg 1992; 75: 287–90
Tanaka K, Yamasaki M. Blocking of cortical inhibitory synapses by intravenous lidocaine. Nature 1966; 209: 207–8
de Jong RH, Robles R, Corbin RW. Central actions of lidocaine-synaptic transmission. Anesthesiology 1969; 30: 19–23
Huffman RD, Yim GK. Effects of diphenylaminoethanol and lidocaine on central inhibition. Int J Neuropharmacol 1969; 8: 217–25
Eriksson E, Persson A. The effect of intravenously administered prilocaine and lidocaine on the human electroencephalogram studied by automatic frequency analysis. Acta Chir Scand 1966; 358 Suppl.: 37–46
Ding Z-N, Yoshita Y, Hirota K, et al. Brain stem auditory evoked potentials during procaine toxicity in dogs. Can J Anaesth 1992; 39: 600–3
Scott DB, Lee A, Fagan D, et al. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989; 69: 563–9
Agarwal R, Gutlove DP, Lockhart CH. Seizures occurring in pediatric patients receiving continuous infusion of bupivacaine. Anesth Analg 1992; 75: 284–6
Berde CB. Convulsions associated with pediatric regional anesthesia [editorial]. Anesth Analg 1992; 75: 164–6
Morishima HO, Finster M, Arthur GR, et al. Pregnancy does not alter lidocaine toxicity. Am J Obstet Gynecol 1990; 162: 1320–4
Bucklin BA, Warner DS, Choi WW, et al. Pregnancy does not alter the threshold for lidocaine-induced seizures in the rat. Anesth Analg 1992; 74: 57–61
Bernards CM, Carpenter RL, Rupp SE, et al. Effect of mid-azolam and diazepam premedication on central nervous system and cardiovascular toxicity of bupivacaine in pigs. Anesthesiology 1989; 70: 318–23
Torbiner ML, Yagiela JA, Mito RS. Effect of midazolam pre-treatment on the intravenous toxicity of lidocaine with and without epinephrine in rats. Anesth Analg 1989; 68: 744–9
De Jong RH, Heavner JE. Local anesthetic seizure prevention: diazepam versus pentobarbital. Anesthesiology 1972; 36: 449–57
Bishop D, Johnstone RE. Lidocaine toxicity treated with low-dose propofol. Anesthesiology 1993; 78: 788–9
Peduto VA, Concas A, Santoro G, et al. Biochemical and electrophysiologic evidence that propofol enhances GABAergic transmission in the rat brain. Anesthesiology 1991; 75: 1000–9
McFarlane C, Warner DS, Dexter F, et al. Glutamatergic antagonism: effects on lidocaine-induced seizures in the rat. Anesth Analg 1994; 79: 701–5
Simon RP, Benowitz NL, Culala S. Motor paralysis increases brain uptake of lidocaine during status epilepticus. Neurology 1984; 34: 384–7
Yokoyama M, Hirakawa M, Goto H. Effect of vasoconstrictive agents added to lidocaine on lidocaine-induced convulsions in rats. Anesthesiology 1995; 82: 574–80
Dripps RD, Vandam LD. Long term follow-up of patients who received 10,098 spinal anesthetics: failure to discover major neurological sequelae. JAMA 1954; 156: 1486–91
Phillips OC, Ebner H, Nelson AT, et al. Neurologic complications following spinal anesthesia with lidocaine: a prospective review of 10,440 cases. Anesthesiology 1969; 30: 284–9
Kane RE. Neurologic deficit following epidural or spinal anesthesia. Anesth Analg 1981; 60: 150–61
Ong BY, Cohen MM, Esmail A, et al. Paresthesias and motor dysfunction after labor and delivery. Anesth Analg 1987; 66: 18–22
Dahlgren N, Tornebrandt K. Neurological complications after anaesthesia: a follow-up of 18,000 spinal and epidural anaesthetics performed over three years. Acta Anaesthesiol Scand 1995; 39: 872–80
Dawkins CJM. An analysis of the complications of extradural and caudal block. Anaesthesia 1969; 24: 554–63
Drasner K, Rigler ML, Sessler DI, et al. Cauda equina syndrome following intended epidural anesthesia. Anesthesiology 1992; 77: 582–5
Rigler ML, Drasner K, Krejcie TC, et al. Cauda equina syndrome after continuous spinal anesthesia. Anesth Analg 1991; 72: 275–81
Schell RM, Brauer FS, Cole DJ, et al. Persistent sacral nerve root deficit after continuous spinal anaesthesia. Can J Anaesth 1991; 38: 908–11
Schneider M, Ettlin T, Kaufmann M, et al. Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine. Anesth Analg 1993; 76: 1154–7
Cheng ACK. Intended epidural anesthesia as a possible cause of cauda equina syndrome. Anesth Anal 1994; 78: 157–9
Hurley RJ, Lambert DH. Continuous spinal anesthesia with a microcatheter technique: preliminary experience. Anesth Analg 1990; 70: 97–102
Drasner K, Sakura S, Chan VWS, et al. Persistent sacral sensory deficit induced by intrathecal local anesthetic infusion in the rat. Anesthesiology 1994; 80: 847–52
FDA Safety Alert: Cauda equina syndrome associated with use of small-bore catheters in continuous spinal anaesthesia. Washington, DC: Food and Drug Administration, 1992 May 29
Ross BK, Coda B, Heath CM. Local anesthetic distribution in a spinal model: a possible mechanism of neurologic injury after continuous spinal anesthesia. Reg Anesth 1991; 17: 69–77
Beardsley D, Holman S, Gantt R, et al. Transient neurologic deficit after spinal anesthesia: local anesthetic maldistribution with pencil point needles? Anesth Analg 1995; 81: 314–20
Hampl K, Schneider M, Ummenhofer W, et al. Transient neurologic symptoms after spinal anesthesia. Anesth Analg 1995; 81: 1148–53
Sakura S, Chan VWS, Ciriales R, et al. The addition of 7.5% glucose does not alter the neurotoxicity of 5% lidocaine administered intrathecally in the rat. Anesthesiology 1995; 82: 236–40
Ready LB, Plumer MH, Haschke RH, et al. Neurotoxicity of local anesthetics in rabbits. Anesthesiology 1985; 64: 364–70
Lambert LA, Lambert DH, Strichartz GR. Irreversible conduction block in isolated nerve by high concentrations of local anesthetics. Anesthesiology 1994; 80: 1082–93
Kroin JS, Penn RD, Levy FE, et al. Effect of repetitive lidocaine infusion on peripheral nerve. Exp Neurol 1986; 94: 166–73
Powell HC, Kalichman MW, Garrett RS, et al. Selective vulnerability of unmyelinated fiber Schwann cells in nerves exposed to local anesthetics. Lab Invest 1988; 59: 271–80
Bromage PR. ’Paraplegia following epidural analgesia’: a misnomer. Anaesthesia 1976; 31: 947–8
Snyder R, Hui G, Flugstad P, et al. More cases of possible neurologic toxicity associated with single subarachnoid injections of 5% hyperbaric lidocaine [letter]. Anesth Analg 1994; 78: 411
Bromage PR. Neurological complications of subarachnoid and epidural anaesthesia [editorial]. Acta Anaesthesiol Scand 1997; 41: 439–44
de Jong RH. Last round for a ‘heavyweight’ [editorial]. Anesth Analg 1994; 78: 3–4
Carpenter RL. Hyperbaric lidocaine spinal anesthesia: Do we need an alternative? [editorial]. Anesth Analg 1995; 81: 1125–8
Scott DB, Hibbart BM. Serious non-fatal complications associated with extradural block in obstetric practice. Br J Anaesth 1990; 64: 537–41
Crawford JS. Some maternal complications of epidural analgesia in labour. Anaesthesia 1985; 40: 1219–25
Eng RHK, Seligman SJ. Lumber puncture induced meningitis. JAMA 1981; 245: 1456–9
Greene NM. Neurological sequalae of spinal anesthesia. Anesthesiology 1961; 22: 682–98
Goldmann WW, Sandford JP. An epidemic of chemical meningitis. Am J Med 1960; 29: 94–101
Harding SA, Collis RE, Morgan BM. Meningitis after combined spinal-epidural in obstetrics. Br J Anaesth 1994; 75: 545–7
Roberts SP, Petts HV. Meningitis after obstetric spinal anaesthesia. Anaesthesia 1990; 45: 376–7
Sansome ATJ, Barnes GR, Barret RF. An unusual presentation of meningitis as a consequence of inadvertent dural puncture. Int J Obst Anaesth 1991; 1: 35–7
Lee JJ, Parry H. Bacterial meningitis following spinal anaesthesia for Caesarean section. Br J Anaesth 1991; 66: 383–6
Davis L, Hargreaves C, Robinson PN. Postpartum meningitis. Anaesthesia 1993; 48: 788–9
Burke D, Wildsmith JAW. Meningitis after spinal anaesthesia [editorial]. Br J Anaesth 1997; 78: 635–6
Marinac JS. Drug and chemical induced meningitis: a review of the literature. Ann Pharmacother 1992; 26: 813–21
Seigne TD. Aseptic meningitis following spinal analgesia. Anaesthesia 1970; 25: 402–7
Blackmore TK, Morley HR, Gordon DL. Streptococcus mitis— induced bacteremia and meningitis after spinal anesthesia. Anesthesiology 1993; 78: 592–4
Wildsmith JAW. Regional anaesthesia requires attention to detail [letter]. Br J Anaesth 1991; 67: 224–5
Neumark J, Feichtinger W, Gassner A. Epidural block in obstetrics followed by meningoencephalitis. Anesthesiology 1980; 52: 518–9
Berga S, Trierweiler M. Bacterial meningitis following epidural anesthesia for vaginal delivery: a case report. Am J Obstet Gynecol 1989; 74: 437–9
Kehlet H. Surgical stress — the role of pain and analgesia. Br J Anaesth 1989; 63: 189–95
Kehlet H. Epidural analgesia and the endocrine-metabolic response to surgery: update and perspectives. Acta Anaesthesiol Scand 1984; 28: 125–7
Engquist A, Brandt MR, Fernandes A, et al. The blocking effect of epidural analgesia on the adrenocortical and hyperglycaemic responses to surgery. Acta Anaesthesiol Scand 1977; 21: 330–5
Moore CM, Cross MH, Desborough JP, et al. Hormonal effects of thoracic extradural analgesia for cardiac surgery. Br J Anaesth 1995; 75: 387–93
Moore CM, Desborough JP, Powell H, et al. Effects of extradural anaesthesia on interleukin-6 and acute phase response to surgery. Br J Anaesth 1994; 72: 272–5
Salo M. Effects of anaesthesia and surgery on the immune response. Acta Anaesthesiol Scand 1992; 36: 201–20
Lee DD, Kimura S, De Quattro V. Noradrenergic activity and silent ischemia in hypertensive patients with stable angina: effect of metoprolol. Lancet 1989; I: 403–6
Hasselstrom LJ, Mogensen T, Kehlet H, et al. Effects of intravenous bupivacaine on cardiovascular function and plasma catecholamine levels in humans. Anesth Analg 1984; 63: 1053–8
Romano E, Gullo A. Hypoglycaemic coma following epidural analgesia. Anaesthesia 1980; 35: 1084–6
Brennan L, Halfacre JA, Woods SD. Regional anaesthesia in porphyria. Br J Anaesth 1990; 65: 594–7
McNeill MJ, Bennet A. Use of regional anaesthesia in a patient with acute porphyria. Br J Anaesth 1990; 64: 371–3
Harrison GG, Meissner PN, Hift RJ. Anaesthesia for the porphyric patient. Anaesthesia 1993; 48: 417–21
Parikh RK, Moore MR. Effect of certain anesthetic agents on the activity of rat hepatic delta-aminolevulinate synthase. Br J Anaesth 1978; 50: 1099–103
Jensen NF, Fiddler DS, Striepe V. Anesthetic considerations in porphyrias. Anesth Analg 1995; 80: 591–9
Imrie MM, Hall GH. Body temperature and anaesthesia. Br J Anaesth 1990; 64: 346–54
Ozaki M, Kurz A, Sessler DI, et al. Thermoregulatory thresholds during epidural and spinal anesthesia. Anesthesiology 1994; 81: 282–8
Hynson JM, Sessler DI, Glosten B, et al. Thermal balance and tremor patterns during epidural anesthesia. Anesthesiology 1991; 74: 680–90
Emerick TH, Ozaki M, Sessler DI, et al. Epidural anesthesia increases apparent leg temperature and decreases the shivering threshold. Anesthesiology 1994; 81: 289–98
Joris J, Ozaki M, Sessler DI, et al. Epidural anesthesia impairs both central and peripheral thermoregulatory control during general anesthesia. Anesthesiology 1994; 80: 268–77
Camann WR, Hortvet LA, Hughes N, et al. Maternal temperature regulation during extradural analgesia for labour. Br J Anaesth 1991; 67: 565–8
Henkin RL. Drug-induced taste and smell disorders: incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction. Drug Saf 1994; 11: 318–77
Hacker JF III, Cattau Jr EL. Effects of nasopharyngeal cocaine or pharyngeal benzocaine on esophageal motility. Am J Gastroenterol 1987; 82: 127–9
Crocker JS, Vandam LD. Concerning nausea and vomiting during spinal anesthesia. Anesthesiology 1959; 20: 587–92
Ratra CK, Badola RP, Bhargava KP. A study of factors concerned in emesis during spinal anaesthesia. Br J Anaesth 1972; 44: 1208–11
Palazzo MGA, Strunin L. Anaesthesia and emesis: I: etiology. Can Anaesth Soc J 1984; 31: 178–87
Dent SJ, Ramachandra V, Stephen CR. Postoperative vomiting: incidence, analysis, and therapeutic measures in 3,000 patients. Anesthesiology 1955; 16: 564–72
Juhani TP, Hannele H. Complications during spinal anesthesia for cesarean delivery: a clinical report of one year’s experience. Reg Anesth 1993; 18: 128–31
Griffin RP, Reynolds F. Extradural anaesthesia for Caesarean section: a double-blind comparison of 0.5% ropivacaine with 0.5% bupivacaine. Br J Anaesth 1995; 74: 512–6
Wolff AP, Hasselstrom L, Kerkkamp HE, et al. Extradural ropivacaine and bupivacaine in hip surgery. Br J Anaesthesia 1995; 74: 458–60
Badner NH, Reid D, Sullivan P, et al. Continuous epidural infusion of ropivacaine for the prevention of postoperative pain after major orthopaedic surgery: a dose-finding study. Can J Anaesth 1996; 43: 17–22
Hickey R, Hoffman J, Ramamurthy S. A comparison of ropivacaine 0.5% and bupivacaine 0.5% for brachial plexus block. Anesthesiology 1991; 74: 639–42
Clark RB, Thompson DS, Thompson CH. Prevention of spinal hypotension associated with cesarean section. Anesthesiology 1976; 45: 670–4
Lussos SA, Bader AM, Thornhill ML, et al. The antiemetic efficacy and safety of prophylactic metoclopramide for elective cesarean delivery during spinal anesthesia. Reg Anesth 1992; 17: 126–30
Freudenberger RS, Cappell MS, Hutt DA. Intestinal infarction after intravenous cocaine administration. Ann Intern Med 1990; 113: 715–6
Brandus V, Joffe S, Benoit CV, et al. Bronchial spasm during general anesthesia. Can Anaesth Soc J 1970; 17: 269–74
Downes H, Loehning RW. Local anesthetic contracture and relaxation of airway smooth muscle. Anesthesiology 1977; 47: 430–6
Weiss ER, Anderson WH, O’Brien KP. The effect of a local anesthetic, lidocaine, on guinea pig trachealis muscle in vitro. Am Rev Respir Dis 1975; 112: 393–400
Mallampati SR. Bronchospasm during spinal anesthesia. Anesth Analg 1981; 60: 839–40
Thiagarajah S, Lear E, Azar I, et al. Bronchospasm following interscalene brachial plexus block. Anesthesiology 1984; 61: 759–61
Dahlstrom A, Fuxe K, Hokfelt T, et al. Adrenergic innervation of the bronchial muscle of the cat. Acta Physiol Scand 1966; 66: 507–8
Lumb AB, Carli F. Respiratory arrest after a caudal injection of bupivacaine. Anaesthesia 1989; 44: 324–5
Cory PC, Mulroy MF. Postoperative respiratory failure following intercostal block. Anesthesiology 1981; 54: 418–9
Rodman DJ, Notaro S, Peer GL. Respiratory depression following retrobulbar bupivacaine: three case reports and literature review. Ophthalmic Surg 1987; 18: 768–71
Holmboe J, Kongsrud F. Delayed respiratory arrest after bupivacaine. Anaesthesia 1982; 37: 60–2
Parnass SM, Schmidt KJ. Adverse effects of spinal and epidural anaesthesia. Drug Saf 1990; 5: 179–94
Howard JJ, Mohsenifar Z, Simons SM. Adult respiratory distress syndrome following administration of lidocaine. Chest 1982; 81: 644–5
McBurney A, Jones DA, Stanley PJ, et al. Absorption of lignocaine and bupivacaine from the respiratory tract during fibreoptic bronchoscopy. Br J Clin Pharmacol 1984; 17: 61–6
Uehira A, Tanaka A, Oda M, et al. Obstruction of an endotracheal tube by lidocaine jelly. Anesthesiology 1981; 55: 598–9
Levin ML, O’Connor PS. Visual acuity after retrobulbar anesthesia. Ann Ophthalmol 1989; 11: 337–9
Brent BD, Singh H. The effect of retrobulbar anesthesia on visual acuity in planned extracapsular cataract extraction. Ophthalmic Surg 1991; 22: 392–5
Cowley M, Campochiaro PA, Newman SA, et al. Retinal vascular occlusion without retrobulbar or optic nerve sheath hemorrhage after retrobulbar injection of lidocaine. Ophthalmic Surg 1988; 19: 859–61
Vester-Andersen T, Christiansen C, Hansen A, et al. Interscalene brachial plexus block: area of analgesia, complications and blood concentrations of local anesthetics. Acta Anaesthesiol Scand 1981; 25: 81–4
Hickey R, Garland TA, Ramaurthy S. Subclavian perivascular block: influence of location of paresthesia. Anesth Analg 1989; 68: 767–71
Mohan J, Potter JM. Pupillary constriction and ptosis following caudal epidural analgesia. Anaesthesia 1975; 30: 769–73
Clayton KC. The incidence of Horner’s syndrome during lumbar extradural for elective caesarean section and provision of analgesia during labour. Anaesthesia 1983; 8: 583–5
Mohan J, Lloyd JW, Potter JM. Pupillary constriction following extradural analgesia. Injury 1973; 5: 151–2
Winnie AP, Ramamurthy S, Durrani Z, et al. Pharmacological reversal of Horner’s syndrome following stellate ganglion block. Anesthesiology 1974; 41: 615–7
Hamilton RC, Gimbel HV, Strunin L. Regional anaesthesia for 12000 cataract extraction and intraocular lens implantation procedures. Can J Anaesth 1988; 35: 615–23
Rao VA, Kawatra VK. Ocular myotoxic effects of local anaesthetics. Can J Ophthalmol 1988; 23: 171–3
De Faber JT, Von Noorden GK. Inferior rectus muscle palsy after retrobulbar anesthesia for cataract surgery. Am J Ophthalmol 1991; 112: 209–11
Hamed LM, Mancuso A. Inferior rectus muscle contracture syndrome after retrobulbar anesthesia. Ophthalmology 1991; 98: 1506–12
Ong-Tone L, Pearce WG. Inferior rectus muscle restriction after retrobulbar anaesthesia for cataract extraction. Can J Ophthalmol 1989; 24: 162–5
Carlson BM, Rainin EA. Rat extraocular muscle regeneration: repair of local anesthetic-induced damage. Arch Ophthalmol 1985; 103: 1373–7
Rainin EA, Carlson BM. Postoperative diplopia and ptosis: a clinical hypothesis based on the myotoxicity of local anesthetics. Arch Ophthalmol 1985; 103: 1337–9
Yagiela JA, Benoit PW, Buoncristiani RD, et al. Comparison of myotoxic effects of lidocaine with epinephrine in rats and humans. Anesth Analg 1981; 60: 471–80
Foster AH, Carlson BM. Myotoxicity of local anesthetics and regeneration of the damaged muscle fibers. Anesth Analg 1980; 59: 727–36
Brun A. Effect of procaine, Carbocaine and xylocaine on cutaneous muscle in rabbits and mice. Acta Anaesthesiol Scand 1959; 3: 59–73
Benoit PW, Belt D. Destruction and regeneration of skeletal muscle after treatment with a local anesthetic, bupivacaine (Marcaine). J Anat 1970; 107: 547–56
Benoit PW, Belt WD. Some effects of local anesthetic agents on skeletal muscle. Exp Neurol 1972; 34: 264–78
Guttu RL, Page DG, Laskin DM. Delayed healing of muscle after injection of bupivacaine and steroid. Ann Dent 1990; 49: 5–8
Benoit PW. Reversible skeletal muscle damage after administration of local anesthetics with and without epinephrine. J Oral Surg 1978; 36: 198–201
Komorowski TE, Shepard B, Okland S, et al. An electron microscopic study of local anesthetic-induced skeletal muscle fiber degeneration and regeneration in the monkey. J Orthop Res 1990; 8: 495–503
Schultz E, Lipton BH. The effect of Marcaine on muscle and non-muscle cells in vitro. Anat Res 1978; 191: 351–69
Benoit PW, Yagiela JA, Fort NF. Pharmacological correlation between local anesthetic-induced myotoxicity and disturbances of intracellular calcium distribution. Toxicol Appl Pharmacol 1980; 52: 187–98
Brownell AKW, Paasuke RT. Use of local anesthetics in malignant hyperthermia. Can Med Assoc J 1986; 134: 993–4
Adragna MG. Medical protocol by habit — the avoidance of amide local anesthetics in malignant hyperthermia susceptible patients. Anesthesiology 1985; 62: 99–100
MacArthur C, Lewis M, Knox EG, et al. Epidural anaesthesia and long term backache after childbirth. BMJ 1990; 301: 9–12
Grove LH. Backache, headache and bladder dysfunction after delivery. Br J Anaesth 1973; 45: 1147–9
Stevens RA, Chester WL, Artuso JD, et al. Back pain after epidural anesthesia in volunteers: a preliminary report. Reg Anesth 1991; 16: 199–203
Hynson JM, Sessler DI, Glosten B. Back pain in volunteers after epidural anesthesia with chloroprocaine. Anesth Analg 1991; 72: 253–6
Levy L, Randel GI, Pandit SK. Does chloroprocaine (Nesacaine MPF) for epidural anesthesia increase the incidence of backache? [letter] Anesthesiology 1989; 71: 476
Stevens RA, Urmey WE, Urquhart BL, et al. Back pain after epidural anesthesia with chloroprocaine. Anesthesiology 1993; 78: 492–7
Bircher AJ, Messmer SL, Surber C, et al. Delayed-type hyper-sensitivity to subcutaneous lidocaine with tolerance to articaine: confirmation by in vivo and in vitro tests. Contact Dermatitis 1996; 34: 387–9
Rood JP. A case of lignocaine hypersensitivity. Br Dent J 1973; 135: 411–2
Yeoman CM. Hypersensitivity to prilocaine. Br Dent J 1982; 153: 69–70
Moriwaki K, Higaki A, Sasaki H, et al. A case report of anaphylactic shock induced by tetracaine used for spinal anesthesia. Masui 1986; 35: 1279–84
Promisloff RA, DuPont DC. Death from ARDS and cardiovascular collapse following lidocaine administration [letter]. Chest 1983; 83: 585
Brown DT, Beamish D, Wildsmith JA. Allergic reaction to an amide local anesthetic. Br J Anaesth 1981; 53: 435–7
Ruzicka T, Gerstmeir M, Przybilla B, et al. Allergy to local anesthetics: comparison of patch test with prick and intradermal test results. J Am Acad Dermatol 1987; 16: 1202–8
Fisher MM, Pennington JC. Allergy to local anesthesia. Br J Anaesth 1982; 54: 893–94
Fisher MM, Graham R. Adverse responses to local anesthetics. Anaesth Intens Care 1984; 12: 325–7
Chandler MJ, Grammer LC, Patterson R. Provocative challenge with local anesthetics in patients with a prior history of reactions. J Allergy Clin Immunol 1987; 79: 883–6
Watkins J. Second report from an anaesthetic reactions advisory service. Anaesthesia 1989; 44: 157–9
Fung DL, Schatz H. Surgery in allergic patients. In: Bierman CW, Pearlman DS, editors. Allergic diseases from infancy to adulthood. Philadelphia: WB Saunders, 1988: 748–59
Weiss ME. Drug allergy. Med Clin North Am 1992; 76: 857–82
Stoelting RK. Allergic reactions during anesthesia. Anesth Analg 1983; 62: 341–56
McKinnon RP, Wildsmith JAW. Histaminoid reactions in anaesthesia. Br J Anaesth 1995; 74: 217–28
Ralston DH, Shnider SM. The fetal and neonatal effects of regional anesthesia in obstetrics. Anesthesiology 1978; 48: 34–64
Brizgys RV, Dailey PA, Shnider SM, et al. The incidence and neonatal effects of maternal hypotension during epidural anesthesia for cesarean section. Anesthesiology 1987; 67: 782–6
Jouppila R, Jouppila P, Kuikka J, et al. Placental blood flow during caesarean section under lumbar extradural analgesia. Br J Anaesth 1978; 50: 275–9
Scanlon JW, Brown WU, Weiss JB, et al. Neurobehavioral responses of newborn infants after maternal epidural anesthesia. Anesthesiology 1974; 40: 121–8
Abouleish E. Foetal bradycardia during caudal analgesia: a discussion of possible causative factors. Br J Anaesth 1976; 48: 481–4
Abboud TK, Kim KC, Noueihed R, et al. Epidural bupivacaine, chloroprocaine, or lidocaine for cesarean section — maternal and neonatal effects. Anesth Analg 1983; 62: 914–9
Loftus JR, Holbrook RH, Cohen SE. Fetal heart rate after epidural lidocaine and bupivacaine for elective cesarean section. Anesthesiology 1991; 75: 406–12
Kileff ME, James FM III, Dewan DM, et al. Neonatal neurobehavioral responses after epidural anesthesia for cesarean section using lidocaine and bupivacaine. Anesth Analg 1984; 63: 413–7
Abboud TK, Afrasiabi A, Sarkis F, et al. Continuous infusion epidural analgesia in parturients receiving bupivacaine, chloroprocaine, or lidocaine — maternal, fetal, and neonatal effects. Anesth Analg 1984; 63: 421–8
Stienstra R, Jonker TA, Bourdrez P, et al. Ropivacaine 0.25% versus bupivacaine 0.25% for continuous epidural analgesia in labor: a double-blind comparison. Anesth Analg 1995; 80: 285–9
Brown WR, Bell GC, Alper MH. Acidosis, local anesthesia and the newborn. Obstet Gynecol 1976; 48: 27–30
Van Dorsten JP, Miller FC. Fetal heart rate changes after accidental intrauterine lidocaine. Obstet Gynecol 1981; 57: 257–9
Abouleish EI. Epinephrine improves the quality of spinal hyperbaric bupivacaine for cesarean section. Anesth Analg 1987; 66: 395–400
Eisenach JC, Grice SC, Dewan DM. Epinephrine enhances analgesia produced by epidural bupivacaine during labor. Anesth Analg 1987; 66: 447–51
Chin GN, Almquist HT. Bupivacaine and lidocaine retrobulbar anaesthesia: a double-blind clinical study. Ophthalmology 1983; 90: 369–72
Sinclair CJ, Scott DB. Comparison of bupivacaine and etidocaine in extradural blockade. Br J Anaesth 1984; 56: 147–53
Buckley FP, Littlewood DG, Covino BG, et al. Effects of adrenaline and the concentration of solution on extradural block with etidocaine. Br J Anaesth 1978; 50: 171–5
Racle JP, Benkhadra A, Poy JY, et al. Prolongation of isobaric bupivacaine spinal anesthesia with epinephrine and clonidine for hip surgery in the elderly. Anesth Analg 1987; 66: 442–6
Eledjam JJ, Deschodt J, Viel EJ, et al. Brachial plexus block with bupivacaine: effects of added alpha-adrenergic agonists: comparison between clonidine and epinephrine. Can J Anaesth 1991; 38: 870–5
Nishikawa T, Dohi S. Clinical evaluation of clonidine added to lidocaine solution for epidural anesthesia. Anesthesiology 1990; 73: 853–9
Garty M, Ben-Zvi Z, Hurwitz A. Interaction of clonidine and morphine with lidocaine in mice and rats. Toxicol Appl Pharmacol 1989; 101: 255–60
Bruguerolle B, Attolini L, Lorec AM, et al. Kinetics of bupivacaine after clonidine pretreatment in mice. Can J Anaesth 1995; 42: 434–7
Mazoit JX, Benhamou D, Veillette Y, et al. Clonidine and or adrenaline decrease lignocaine plasma peak concentration after epidural injection. Br J Clin Pharmacol 1996; 42: 242–5
De Kock M, Le Polain B, Henin D, et al. Clonidine pretreatment reduces the systemic toxicity of intravenous bupivacaine in rats. Anesthesiology 1993; 79: 282–9
Yokoyama M, Hirakawa M, Goto H. Clonidine does not affect lidocaine seizure threshold in rats. Can J Anaesth 1993; 40: 1205–9
Nicoll JMV, Treuren B, Acharya A, et al. Retrobulbar anesthesia: the role of hyaluronidase. Anesth Analg 1986; 65: 1324–8
Sarvela J, Nikki P. Hyaluronidase improves regional ophthalmic anaesthesia with etidocaine. Can J Anaesth 1992; 39: 920–4
Mindel JS. Value of hyaluronidase in ocular surgical akinesia. Am J Ophthalmol 1978; 85: 643–6
Morsman CD, Holden R. The effects of adrenaline, hyaluronidase and age on peribulbar anaesthesia. Eye 1992; 6: 290–2
Barr J, Kirkpatrick N, Dick A, et al. Effects of adrenaline and hyaluronidase on plasma concentrations of lignocaine and bupivacaine after peribulbar anaesthesia. Br J Anaesth 1995; 75: 692–7
Kaplan JA, Miller Jr ED, Gallagher EG. Postoperative analgesia for thoracotomy patients. Anesth Analg 1975; 54: 773–7
Scurlock JE, Curtis BM. Dextran-local anesthetic interactions. Anesth Analg 1980; 59: 335–40
Mather LE, Tucker GT, Murphy TM, et al. Hemodynamic drug interaction: peridural lidocaine and intravenous ephedrine. Acta Anaesthesiol Scand 1976; 20: 207–10
Herzig S, Ruhnke L, Wulf H. Functional interaction between local anaesthetics and calcium antagonists in guineapig myocardium: 1. Cardiodepressant effects in isolated organs. Br J Anaesth 1994; 73: 357–63
Geraets DR, Scott SD, Ballew KA. Toxicity potential of oral lidocaine in a patient receiving mexiletine. Ann Pharmacother 1992; 26: 1380–1
Christie JM, Valdes C, Markowsky SJ. Neurotoxicity of lidocaine combined with mexiletine. Anesth Analg 1993; 77: 1291–4
Ellrodt G, Singh BN. Adverse effects of disopyramide (Norpace): toxic interactions with other antiarrhythmic agents. Heart Lung 1980; 9: 469–74
Ilyas M, Owens D, Kvasnicka G. Delirium induced by a combination of anti-arrhythmic drugs. Lancet 1969; II: 1368–9
Keidar S, Grenadier E, Palant A. Sinoatrial arrest due to lidocaine injection in sick sinus syndrome during amiodarone administration. Am Heart J 1982; 104: 1384–5
Nattel S, Talajic M, Beaudoin D, et al. Absence of pharmacokinetic interaction between amiodarone and lidocaine. Am J Cardiol 1994; 73: 92–4
Heinonen J, Takkis S, Jarho L. Plasma lidocaine levels in patients treated with potential inducers of microsomal enzymes. Acta Anaesthesiol Scand 1970; 14: 89–95
Perucca E, Hedges A, Makki KA, et al. A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme inducing drugs. Br J Clin Pharmacol 1980; 10: 491–7
Bruguerolle B. Effects of calcium channel blockers on bupivacaine-induced toxicity. Life Sci 1993; 53: 349–53
Bruguerolle B, Lorec AM. Bupivacaine kinetic changes induced by diltiazem in mice. Life Sci 1994; 54: 315–9
Hyman SA, Kinney WW, Horn J-L, et al. Nimodipine reduces the toxicity of intravenous bupivacaine in rats. Anesth Analg 1992; 74: 851–5
Conrad KA, Byers MJ III, Finley PR, et al. Lidocaine elimination: effects of metoprolol and of propranolol. Clin Pharmacol Ther 1983; 33: 133–8
Ochs HR, Carstens G, Greenblatt DJ. Reduction in lidocaine clearance during continuous infusion and by coadministration of propranolol. N Engl J Med 1980; 303: 373–8
Schneck DW, Luderer JR, Davis D, et al. Effects of nadolol and propranolol on plasma lidocaine clearance. Clin Pharmacol Ther 1984; 36: 584–7
Ponten J, Biber B, Bruro T, et al. Beta-receptor blockade and spinal anaesthesia: withdrawal versus continuation of long-term therapy. Acta Anaesthesiol Scand 1982; 76 Suppl.: 62–9
Ponten J, Biber B, Henriksson BA, et al. Bupivacaine for intercostal nerve blockade in patients on long-term beta-receptor blocking therapy. Acta Anaesthesiol Scand 1982; 76 Suppl.: 70–77
Hartrick CT, Dirkes WE, Raj PP. Influence of bupivacaine on mepivacaine protein binding. Clin Pharmacol Ther 1984; 36: 546–50
Ghoneim MM, Pandya H. Plasma protein binding of bupivacaine and its interaction with other drugs in man. Br J Anaesth 1974; 46: 435–8
Feely J, Guy E. Lack of effect of ranitidine on the disposition of lignocaine. Br J Clin Pharmacol 1983; 15: 378–9
Jackson JE, Bentley JB, Glass S, et al. Effects of histamine-2 receptor blockade on lidocaine kinetics. Clin Pharmacol Ther 1985; 37: 544–8
Klotz U. Lack of effect of nizatidine on drug metabolism. Scand J Gastroenterol 1987; 22 Suppl. 136: 18–23
Feely, Wilkinson GR, McAllister CB, et al. Increased toxicity and reduced clearance of lidocaine by cimetidine. Ann Intern Med 1982; 96: 592–4
Kuhnert BR, Zuspan KJ, Kuhnert PM, et al. Lack of influence of cimetidine on bupivacaine levels during parturition. Anesth Analg 1987; 66: 986–90
Flynn RJ, Moore J, Collier PS, et al. Does pretreatment with cimetidine and ranitidine affect the disposition of bupivacaine? Br J Anaesth 1989; 62: 87–91
Calvo R, Carlos R, Erill S. Effects of disease and acetazolamide on procaine hydrolysis by red blood cell enzymes. Clin Pharmacol Ther 1980; 27: 179–83
Brodsky JB, Campos FA. Chloroprocaine analgesia in a patient receiving echothiophate iodide eye drops. Anesthesiology 1978; 48: 288–9
Carabine UA, Wright PMC, Moore J. Extradural clonidine and bupivacaine for postoperative analgesia. Br J Anaesth 1992; 68: 132–5
Bonnet F, Brun-Buisson V, Saada M, et al. Dose-related prolongation of hyperbaric tetracaine spinal anesthesia by clonidine in humans. Anesth Analg 1989; 68: 619–22
Carp H, Jayaram A, Morrow D. Intrathecal cholinergic agonists lessen bupivacaine spinal-block-induced hypotension in rats. Anesth Analg 1994; 79: 112–6
Foster CA, Aston SJ. Propranolol-epinephrine interaction: a potential disaster. Plast Reconstr Surg 1983; 72: 74–8
Dzubow LM. The interaction between propranolol and epinephrine as observed in patients undergoing Mohs’ surgery. J Am Acad Dermatol 1986; 15: 71–5
Wood RA. Sinoatrial arrest: an interaction between phenytoin and lignocaine. BMJ 1971; 1: 645
Matsuo S, Rao DB, Chaudry I, et al. Interaction of muscle relaxants and local anesthetics at the neuromuscular junction. Anesth Analg 1978; 57: 580–7
Harrah MD, Way WL, Katzung BG. The interaction of d-tubocurarine with antiarrhythmic drugs. Anesthesiology 1970; 33: 406–10
Bruckner J, Thomas Jr KC, Bikhazi GB, et al. Neuromuscular drug interactions of clinical importance. Anesth Analg 1980; 59: 678–82
Himes Jr RS, DiFazio CA, Burney RG. Effects of lidocaine on the anesthetic requirements for nitrous oxide and halothane. Anesthesiology 1977; 47: 437–40
Bruguerolle B, Emperaire N. Flumazenil and bupivacaine-induced toxicity: inverse agonist type activity. Life Sci 1991; 49: 185–8
Bruguerolle B, Lorec AM. Lack of bupivacaine kinetic changes induced by flumazenil in mice. Life Sci 1993; 52: 165–7
Åkerman B, Arweström E, Post C. Local anesthetics potentiate spinal morphine antinociception. Anesth Analg 1988; 67: 943–8
Maves TJ, Gebhart GF. Antinociceptive synergy between intrathecal morphine and lidocaine during visceral and somatic nociception in the rat. Anesthesiology 1992; 76: 91–9
Abouleish E, Rawal N, Shaw J, et al. Intrathecal morphine 0.2 mg versus epidural bupivacaine 0.125% or their combination: effects on parturients. Anesthesiology 1991; 74: 711–6
Hunt CO, Naulty JS, Bader AM, et al. Perioperative analgesia with subarachnoid fentanyl-bupivacaine for cesarean delivery. Anesthesiology 1989; 71: 535–40
Omoigui S. The anesthesia drugs handbook. 2nd ed. St Louis, MO: Mosby-Year Book Inc., 1995: 48–341
Brown DL, Ransom DM, Hall JA, et al. Regional anesthesia and local anesthetic-induced systemic toxicity: seizure frequency and accompanying cardiovascular changes. Anesth Analg 1995; 81: 321–8
Tanaka K, Watanabe R, Harada T, et al. Extensive application of epidural anesthesia and analgesia in a university hospital: incidence of complications related to technique. Reg Anesth 1993; 18: 34–8
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Naguib, M., Magboul, M.M.A., Samarkandi, A.H. et al. Adverse Effects and Drug Interactions Associated with Local and Regional Anaesthesia. Drug-Safety 18, 221–250 (1998). https://doi.org/10.2165/00002018-199818040-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199818040-00001